Company: PHR
Filing Date: 2025-09-05
Form Type: 10-Q
Source: 0001412408-25-000062
Chunk: 146

Company: Phreesia, Inc.
Filing Date: 2025-09-05
Form: 10-Q
Item: Part I, Item 8
Chunk 146
---
, respectively.(d) Intangible assets and goodwillThe following presents the details of intangible assets as of July 31, 2025 and January 31, 2025:Useful Life (years)July 31, 2025January 31, 2025Acquired technology5 to 7$9,310 $9,310 Customer relationship7 to 1517,940 17,940 License156,200 6,200 Trademarks153,100 3,100 Total intangible assets, gross carrying value$36,550 $36,550 Less: accumulated amortization(10,147)(8,407)Net carrying value$26,403 $28,143 The weighted average remaining useful life for acquired technology in years was 4.6 and 5.1 as of July 31, 2025 and January 31, 2025, respectively. The remaining useful life for customer relationships in years was 11.2 and 11.6 as of July 31, 2025 and January 31, 2025, respectively. The remaining useful life for the license to the Patient Activation Measure ("PAM"®) in years was 11.4 and 11.8 as of July 31, 2025 and January 31, 2025, respectively. The remaining useful life for the trademarks in years was 13.0 and 13.5 as of July 31, 2025 and January 31, 2025, respectively.Amortization expense associated with intangible assets for each of the three months ended July 31, 2025 and 2024, was $871 and for each of the six months ended July 31, 2025 and 2024, was $1,741.The estimated amortization expense for intangible assets for the next five years and thereafter was as follows as of July 31, 2025:July 31, 20252026 (Remaining six months)$1,711 Fiscal year ending January 31,20273,157 20283,157 20293,057 2030 - thereafter15,321 Total$26,403 There were no changes to the Company's goodwill balance during the six months ended July 31, 2025. The Company did not record any impairments of goodwill during the three and six months ended July 31, 2025 or 2024